BIOMAT Database Logo BIOMAT Database Logo

Valproic acid versus ethosuximide in the treatment of absence seizures. 1982

S Sato, and B G White, and J K Penry, and F E Dreifuss, and J C Sackellares, and H J Kupferberg

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D004832 Epilepsy, Absence A seizure disorder usually occurring in childhood characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. (Menkes, Textbook of Child Neurology, 5th ed, p736) Akinetic Petit Mal,Epilepsy, Minor,Petit Mal Epilepsy,Pyknolepsy,Absence Seizure Disorder,Childhood Absence Epilepsy,Epilepsy Juvenile Absence,Epilepsy, Absence, Atypical,Epilepsy, Petit Mal,Juvenile Absence Epilepsy,Pykno-Epilepsy,Seizure Disorder, Absence,Absence Epilepsy,Absence Epilepsy, Childhood,Absence Epilepsy, Juvenile,Absence Seizure Disorders,Epilepsy, Childhood Absence,Epilepsy, Juvenile Absence,Minor Epilepsy,Petit Mal, Akinetic,Pykno Epilepsy,Pyknolepsies,Seizure Disorders, Absence
D005013 Ethosuximide An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures. Ethosuccimid,Emeside,Ethylmethylsuccimide,Ethymal,Etosuximida Faes,Petnidan,Pyknolepsinum,Suksilep,Suxilep,Zarontin,Faes, Etosuximida
D005071 Evoked Potentials Electrical responses recorded from nerve, muscle, SENSORY RECEPTOR, or area of the CENTRAL NERVOUS SYSTEM following stimulation. They range from less than a microvolt to several microvolts. The evoked potential can be auditory (EVOKED POTENTIALS, AUDITORY), somatosensory (EVOKED POTENTIALS, SOMATOSENSORY), visual (EVOKED POTENTIALS, VISUAL), or motor (EVOKED POTENTIALS, MOTOR), or other modalities that have been reported. Event Related Potential,Event-Related Potentials,Evoked Potential,N100 Evoked Potential,P50 Evoked Potential,N1 Wave,N100 Evoked Potentials,N2 Wave,N200 Evoked Potentials,N3 Wave,N300 Evoked Potentials,N4 Wave,N400 Evoked Potentials,P2 Wave,P200 Evoked Potentials,P50 Evoked Potentials,P50 Wave,P600 Evoked Potentials,Potentials, Event-Related,Event Related Potentials,Event-Related Potential,Evoked Potential, N100,Evoked Potential, N200,Evoked Potential, N300,Evoked Potential, N400,Evoked Potential, P200,Evoked Potential, P50,Evoked Potential, P600,Evoked Potentials, N100,Evoked Potentials, N200,Evoked Potentials, N300,Evoked Potentials, N400,Evoked Potentials, P200,Evoked Potentials, P50,Evoked Potentials, P600,N1 Waves,N2 Waves,N200 Evoked Potential,N3 Waves,N300 Evoked Potential,N4 Waves,N400 Evoked Potential,P2 Waves,P200 Evoked Potential,P50 Waves,P600 Evoked Potential,Potential, Event Related,Potential, Event-Related,Potential, Evoked,Potentials, Event Related,Potentials, Evoked,Potentials, N400 Evoked,Related Potential, Event,Related Potentials, Event,Wave, N1,Wave, N2,Wave, N3,Wave, N4,Wave, P2,Wave, P50,Waves, N1,Waves, N2,Waves, N3,Waves, N4,Waves, P2,Waves, P50

Related Publications

S Sato, and B G White, and J K Penry, and F E Dreifuss, and J C Sackellares, and H J Kupferberg
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
March 2010, The New England journal of medicine,
S Sato, and B G White, and J K Penry, and F E Dreifuss, and J C Sackellares, and H J Kupferberg
Ethosuximide in the treatment of absence (peptit mal) seizures.
June 1975, Neurology,
S Sato, and B G White, and J K Penry, and F E Dreifuss, and J C Sackellares, and H J Kupferberg
Absence seizures aggravated by valproic acid.
July 2001, Epilepsia,
S Sato, and B G White, and J K Penry, and F E Dreifuss, and J C Sackellares, and H J Kupferberg
Absence seizures: valproate or ethosuximide?
January 1983, Acta neurologica Scandinavica. Supplementum,
S Sato, and B G White, and J K Penry, and F E Dreifuss, and J C Sackellares, and H J Kupferberg
Valproic acid and ethosuximide interaction.
June 1980, Annals of neurology,
S Sato, and B G White, and J K Penry, and F E Dreifuss, and J C Sackellares, and H J Kupferberg
Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
May 2012, Brain & development,
S Sato, and B G White, and J K Penry, and F E Dreifuss, and J C Sackellares, and H J Kupferberg
[Idiopathic generalized epilepsies with absence seizures with valproic acid treatment: neuropsychological disorders].
July 2012, Revista de neurologia,
S Sato, and B G White, and J K Penry, and F E Dreifuss, and J C Sackellares, and H J Kupferberg
Valproic acid-ethosuximide interaction: a pharmacokinetic study.
April 1984, Epilepsia,
S Sato, and B G White, and J K Penry, and F E Dreifuss, and J C Sackellares, and H J Kupferberg
Ethosuximide kinetics: possible interaction with valproic acid.
June 1982, Clinical pharmacology and therapeutics,
S Sato, and B G White, and J K Penry, and F E Dreifuss, and J C Sackellares, and H J Kupferberg
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.
January 2013, Epilepsia,
Copied contents to your clipboard!